FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Fenofibrate Capsules
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Mylan Pharmaceuticals Inc. (New 06/19/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
43 mg, 30 count bottle (NDC 0378-6088-93) 06/19/2018 The discontinuation of this product is a business decision.
130 mg, 30 count bottle (NDC 0378-6089-93) 06/19/2018 The discontinuation of this product is a business decision.
130 mg, 90 count bottle (NDC 0378-6089-77) 06/19/2018 The discontinuation of this product is a business decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English